跳至主要内容
临床试验/CTRI/2019/11/021869
CTRI/2019/11/021869已完成3 期

Efficacy and safety of exercise in mild to moderate myasthenia gravis: an openlabeled controlled trial. - RESTOREX MG

Prinicipal Investigator0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. MG patients attending the neurology Outdoor or indoor services of SGPGIMS.
  • 2. MGFA score of stage II to III.
  • 3. Able to undergo 6minute walk test

排除标准

  • 1. Enrolled in another trial. 2. Contraindications to exercise like coronary artery disease and stroke and pulmonary disease, osteoarthritis, pregnancy or medical condition reducing survival to less than 2 years.
  • 3. Hospitalization in past 8 weeks. 4. MGFA score of stage I, IV or V. 5. MGQOL score > 45.

研究者

发起方
Prinicipal Investigator

相似试验